Lynch Thomas P.
Insider CIK 1659824 · OREX EVP. General Counsel & Sec. · CHFS Chief Legal Compliance Officer · BLLN See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-10-13 | 2026-10-19 | 2,000 | $8.65 | $17.3K | 38,974 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-10-13 | 2026-10-19 | 2,000 | $8.65 | $17.3K | 10,700 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-10-08 | 2026-10-13 | 8,000 | $8.65 | $69.2K | 40,974 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-10-08 | 2026-10-13 | 8,000 | $8.65 | $69.2K | 8,700 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 5,840 | $30.78 | $179.8K | 30,834 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 19,384 | $8.65 | $167.7K | 48,974 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 6,968 | $11.55 | $80.5K | 4,063 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 2,920 | $17.12 | $50.0K | 5,417 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 19,384 | $8.65 | $167.7K | 20,084 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 6,968 | $11.55 | $80.5K | 27,052 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 2,920 | $17.12 | $50.0K | 29,972 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 5,840 | $30.78 | $179.8K | 35,812 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 19,384 | $110.36 | $2.14M | 16,428 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 6,968 | $110.30 | $768.6K | 9,460 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 5,840 | $110.29 | $644.1K | 700 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 2,920 | $110.31 | $322.1K | 6,540 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 5,840 | $30.78 | $179.8K | 30,834 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 2,920 | $17.12 | $50.0K | 5,417 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 6,968 | $11.55 | $80.5K | 4,063 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 19,384 | $8.65 | $167.7K | 48,974 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 5,840 | $110.29 | $644.1K | 700 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 2,920 | $110.31 | $322.1K | 6,540 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 6,968 | $110.30 | $768.6K | 9,460 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 19,384 | $110.36 | $2.14M | 16,428 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 5,840 | $30.78 | $179.8K | 35,812 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 2,920 | $17.12 | $50.0K | 29,972 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 6,968 | $11.55 | $80.5K | 27,052 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 19,384 | $8.65 | $167.7K | 20,084 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 11,042 | $8.65 | $95.5K | 68,358 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 3,969 | $11.55 | $45.8K | 11,031 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 1,663 | $17.12 | $28.5K | 8,337 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 3,326 | $30.78 | $102.4K | 36,674 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 1,944 | $98.97 | $192.4K | 18,718 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 8,285 | $100.12 | $829.5K | 10,433 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 775 | $100.83 | $78.1K | 9,658 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 38 | $96.47 | $3.7K | 20,662 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 1,663 | $17.12 | $28.5K | 17,374 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 614 | $99.00 | $60.8K | 9,044 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 2,997 | $100.11 | $300.0K | 6,047 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 576 | $98.89 | $57.0K | 3,450 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 147 | $101.41 | $14.9K | 4,026 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 1,131 | $100.33 | $113.5K | 4,173 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 385 | $99.22 | $38.2K | 5,304 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 2,518 | $100.20 | $252.3K | 932 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 358 | $100.82 | $36.1K | 5,689 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 11,042 | $8.65 | $95.5K | 11,742 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 3,969 | $11.55 | $45.8K | 15,711 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 232 | $100.92 | $23.4K | 700 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 3,326 | $30.78 | $102.4K | 20,700 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 3,326 | $30.78 | $102.4K | 36,674 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 1,663 | $17.12 | $28.5K | 8,337 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 3,969 | $11.55 | $45.8K | 11,031 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise deriv | 2026-09-08 | 2026-09-10 | 11,042 | $8.65 | $95.5K | 68,358 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 232 | $100.92 | $23.4K | 700 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 2,518 | $100.20 | $252.3K | 932 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 576 | $98.89 | $57.0K | 3,450 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 147 | $101.41 | $14.9K | 4,026 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 1,131 | $100.33 | $113.5K | 4,173 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 385 | $99.22 | $38.2K | 5,304 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 358 | $100.82 | $36.1K | 5,689 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 2,997 | $100.11 | $300.0K | 6,047 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 614 | $99.00 | $60.8K | 9,044 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 775 | $100.83 | $78.1K | 9,658 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 8,285 | $100.12 | $829.5K | 10,433 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 1,944 | $98.97 | $192.4K | 18,718 | SEC↗ |
| BLLN BillionToOne, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 38 | $96.47 | $3.7K | 20,662 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 3,326 | $30.78 | $102.4K | 20,700 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 1,663 | $17.12 | $28.5K | 17,374 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 3,969 | $11.55 | $45.8K | 15,711 | SEC↗ |
| BLLN BillionToOne, Inc. | M Exercise | 2026-09-08 | 2026-09-10 | 11,042 | $8.65 | $95.5K | 11,742 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 10,000 | — | $0 | 0 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 40,000 | — | $0 | 0 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 79,400 | — | $0 | 0 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 79,400 | — | $0 | 79,400 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other deriv | 2025-11-07 | 2025-11-12 | 15,000 | — | $0 | 0 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other | 2025-11-07 | 2025-11-12 | 600 | — | $0 | 600 | SEC↗ |
| BLLN BillionToOne, Inc. | J Other | 2025-11-07 | 2025-11-12 | 600 | — | $0 | 0 | SEC↗ |
| BLLN BillionToOne, Inc. | P Buy | 2025-11-07 | 2025-11-12 | 100 | $60.00 | $6.0K | 700 | SEC↗ |
| CHFS CHF Solutions, Inc. | A Award deriv | 2021-01-22 | 2021-01-26 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-10-13 | 2017-10-17 | 69,600 | — | $0 | 69,600 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2017-05-31 | 2017-06-02 | 1,704 | $1.55 | $2.6K | 1,704 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-02-03 | 2017-02-07 | 43,500 | — | $0 | 43,500 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2017-02-03 | 2017-02-07 | 87,000 | — | $0 | 87,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 15,750 | — | $0 | 15,750 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 131,250 | — | $0 | 131,250 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 26,250 | — | $0 | 26,250 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-07-12 | 2016-07-14 | 78,750 | — | $0 | 78,750 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2016-02-02 | 2016-02-04 | 255,000 | — | $0 | 255,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-12-01 | 2015-12-02 | 350,000 | — | $0 | 350,000 | SEC↗ |